Podcast Episodes
Back to Search
Rainbow Rare Earths advances pilot plant, DFS on track
Episode 13794
Rainbow Rare Earths Ltd (LSE:RBW, OTC:RBWRF) CEO George Bennett talked with Proactive's Stephen Gunnion about the company’s strong start to 2026, mar…
3 months, 2 weeks ago
M2i Global partners with Titanium X to strengthen U.S. Titanium supply chain
Episode 13793
M2i Global CEO Alberto Rosende joined Steve Darling from Proactive to announce a new strategic collaboration agreement with Australian-based Titanium…
3 months, 2 weeks ago
Itaconix delivers record $10m+ revenue milestone driven by strong customer momentum
Episode 13792
Itaconix PLC (AIM:ITX, OTCQB:ITXXF) CEO John Shaw talked with Proactive's Stephen Gunnion about the company’s record first-half revenue performance, …
3 months, 2 weeks ago
KEFI Gold eyes main market listing as it transforms into multi-mine producer
Episode 13791
KEFI Gold and Copper PLC (AIM:KEFI, OTC:KFFLF) executive chairman Harry Anagnostaras-Adams talked with Proactive's Stephen Gunnion about the company’…
3 months, 2 weeks ago
Power Probe CEO on IPO, innovation & 2026 growth plans
Episode 13790
Power Probe PLC (AIM:PWR) CEO Chema Garcia talked with Proactive's Stephen Gunnion about the company’s London AIM listing, its innovation-driven grow…
3 months, 2 weeks ago
Alusid CEO on global growth, funding and IPO plans
Episode 13789
Alusid CEO Alasdair Bremner talked with Proactive's Stephen Gunnion about the company’s latest international distribution agreement, funding progress…
3 months, 2 weeks ago
Genflow Biosciences CEO: key catalysts for 2026
Episode 13788
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF) CEO Dr Eric Leire talked with Proactive's Stephen Gunnion about the company’s key programs and upcomi…
3 months, 3 weeks ago
Santhera Pharmaceuticals expands AGAMREE to APAC in $205m deal with Nxera
Episode 13786
Santhera Pharmaceuticals (SIX:SANN) executive vice president for corporate planning and business development Andreas Missy talked with Proactive's St…
3 months, 3 weeks ago
Solvonis CEO on US patent win and PTSD drug progress
Episode 13785
Solvonis Therapeutics PLC (LSE:SVNS) CEO Anthony Tennyson talked with Proactive's Stephen Gunnion about the company’s latest US patent allowance, pro…
3 months, 3 weeks ago
Immunic CEO on key 2025 highlights and 2026 milestones
Episode 13774
Immunic Inc (NASDAQ:IMUX) CEO Dr Daniel Vitt talked with Proactive's Stephen Gunnion about the company’s major milestones in 2025 and key expectation…
3 months, 3 weeks ago